- Home
- RNA vs ASB Comparison
RNA vs ASB Comparison
Compare RNA & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNA | ASB |
|---|---|---|
| Founded | 2012 | 1861 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNA | ASB |
|---|---|---|
| Price | $72.19 | $26.58 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 12 |
| Target Price | ★ $69.26 | $28.00 |
| AVG Volume (30 Days) | ★ 2.3M | 2.1M |
| Earning Date | 11-10-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 3.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | $20,868,000.00 | ★ $1,097,713,000.00 |
| Revenue This Year | $64.11 | $57.84 |
| Revenue Next Year | $37.25 | $9.24 |
| P/E Ratio | ★ N/A | $27.06 |
| Revenue Growth | ★ 106.27 | 8.93 |
| 52 Week Low | $21.51 | $18.32 |
| 52 Week High | $72.61 | $27.58 |
Technical Indicators
Market Signals| Indicator | RNA | ASB |
|---|---|---|
| Relative Strength Index (RSI) | 73.51 | 54.95 |
| Support Level | $71.99 | $26.28 |
| Resistance Level | $72.61 | $26.97 |
| Average True Range (ATR) | 0.28 | 0.50 |
| MACD | -0.37 | -0.04 |
| Stochastic Oscillator | 69.93 | 41.14 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.